Evidence map›Paper›PMID 33667411›Full record

ArticleThe lancet. HIV2021

Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000-20: a modelling study using survey and HIV testing programme data.

Katia Giguère, Jeffrey W Eaton, Kimberly Marsh, Leigh F Johnson, Cheryl C Johnson, Eboi Ehui, Andreas Jahn, Ian Wanyeki, Francisco Mbofana, Fidèle Bakiono and 2 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The lancet. HIV, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06133686 (Implementing Oral), which is not on this map. Cited by 95 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 5 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06133686 phase3not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa: a Phase 3b, Open-label, Hybrid Type 2 Implementation and Effectiveness Trial

TypeinterventionalSponsorMRC/UVRI and LSHTM Uganda Research UnitRan2024 to 2027Enrolled400ConditionsHIVArmsTenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 5 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A cross-sectional survey of men's attitudes towards public health services and their utilisation practices in Limpopo Province, South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 7 countries.

Katia GiguèreDepartment of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montréal, Canada.
Jeffrey W EatonMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Kimberly MarshStrategic Information Department, The Joint United Nations Program on HIV/AIDS (UNAIDS), Geneva, Switzerland.
Leigh F JohnsonCentre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Cheryl C JohnsonGlobal HIV, Hepatitis and Sexually Transmitted Infections Programme, WHO, Geneva, Switzerland; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Eboi EhuiProgramme National de Lutte contre le Sida, Abidjan, Côte d'Ivoire.
Andreas JahnDepartment for HIV and AIDS, Ministry of Health and Population, Lilongwe, Malawi; Ministry of Health, Lilongwe, Malawi and I-TECH, Department of Global Health, University of Washington, Seattle, USA.
Ian WanyekiStrategic Information Department, The Joint United Nations Program on HIV/AIDS (UNAIDS), Geneva, Switzerland.
Francisco MbofanaConselho Nacional de Combate ao HIV/SIDA, Maputo, Mozambique.
Fidèle BakionoConseil National de Lutte contre le Sida et les Infections Sexuellement Transmissibles (CNLS-IST), Ouagadougou, Burkina Faso.
Mary MahyStrategic Information Department, The Joint United Nations Program on HIV/AIDS (UNAIDS), Geneva, Switzerland.
Mathieu Maheu-GirouxDepartment of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montréal, Canada. Electronic address: mathieu.maheu-giroux@mcgill.ca.
Joint United Nations Programme on HIV/AIDS · CHMcGill University · CACentre National de Semences Forestières · BFImperial College London · GBMinistry of Health · MWNational Directorate of Geology · MZUniversity of Cape Town · ZAWorld Health Organization · CH

Funding

CIHRMedical Research Council MR/R015600/1World Health Organization 001
6 · The paper itself

Abstract

backgroundMonitoring knowledge of HIV status among people living with HIV is essential for an effective national HIV response. This study estimates progress and gaps in reaching the UNAIDS 2020 target of 90% knowledge of status, and the efficiency of HIV testing services in sub-Saharan Africa, where two thirds of all people living with HIV reside.

methodsFor this modelling study, we used data from 183 population-based surveys (including more than 2·7 million participants) and national HIV testing programme reports (315 country-years) from 40 countries in sub-Saharan Africa as inputs into a mathematical model to examine trends in knowledge of status among people living with HIV, median time from HIV infection to diagnosis, HIV testing positivity, and proportion of new diagnoses among all positive tests, adjusting for retesting. We included data from 2000 to 2019, and projected results to 2020.

findingsAcross sub-Saharan Africa, knowledge of status steadily increased from 5·7% (95% credible interval [CrI] 4·6-7·0) in 2000 to 84% (82-86) in 2020. 12 countries and one region, southern Africa, reached the 90% target. In 2020, knowledge of status was lower among men (79%, 95% CrI 76-81) than women (87%, 85-89) across sub-Saharan Africa. People living with HIV aged 15-24 years were the least likely to know their status (65%, 62-69), but the largest gap in terms of absolute numbers was among men aged 35-49 years, with 701 000 (95% CrI 611 000-788 000) remaining undiagnosed. As knowledge of status increased from 2000 to 2020, the median time to diagnosis decreased from 9·6 years (9·1-10) to 2·6 years (1·8-3·5), HIV testing positivity declined from 9·0% (7·7-10) to 2·8% (2·1-3·9), and the proportion of first-time diagnoses among all positive tests dropped from 89% (77-96) to 42% (30-55).

interpretationOn the path towards the next UNAIDS target of 95% diagnostic coverage by 2025, and in a context of declining positivity and yield of first-time diagnoses, disparities in knowledge of status must be addressed. Increasing knowledge of status and treatment coverage among older men could be crucial to reducing HIV incidence among women in sub-Saharan Africa, and by extension, reducing mother-to-child transmission.

fundingSteinberg Fund for Interdisciplinary Global Health Research (McGill University); Canadian Institutes of Health Research; Bill & Melinda Gates Foundation; Fonds the recherche du Québec-Santé; UNAIDS; UK Medical Research Council; MRC Centre for Global Infectious Disease Analysis; UK Foreign, Commonwealth & Development Office.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultAfrica South of the SaharaAgedFemaleHealth StatusHIVHIV InfectionsHIV TestingHumansIncidenceInfectious Disease Transmission, VerticalMaleMiddle AgedModels, Statistical

Identifiers

PMID33667411
PMCPMC8097636
OpenAlexW3134860775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.